GL1X · GenesisL1 explorer

MolNFT v1 · #115623 · protein

The effect of isoleucine to alanine mutation on inha enzyme crystallization pattern and substrate binding loop conformation and flexibility

5CP8 · Enoyl-[acyl-carrier-protein] reductase [NADH]: “The effect of isoleucine to alanine mutation on inha enzyme crystallization pattern and substrate binding…”. X-ray diffraction, 3 ligands (NAD, TCU, ETE), 2 pockets (best druggability…

PDB
5CP8
Type
protein
Length
267 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
M9TGV3
Ligands
NAD, TCU, ETE
Pockets
2 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26747% helix, 16% strandM9TGV3

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • TCU · 5-hexyl-2-(2-methylphenoxy)phenol · ligand · chains A
  • ETE · 2-{2-[2-2-(methoxy-ethoxy)-ethoxy]-ethoxy}-ethanol · ligand · chains A
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16420.820.8653NAD, TCU
2670.320.7514empty

Compared structures

  • 5CP8 · The effect of isoleucine to alanine mutation on InhA enzyme crystallization pattern and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.